Cite
HARVARD Citation
Cools, F. et al. (2022). Thromboprophylactic low-molecular-weight heparin versus standard of care in unvaccinated, at-risk outpatients with COVID-19 (ETHIC): an open-label, multicentre, randomised, controlled, phase 3b trial. Lancet. 9 (8), pp. e594-e604. [Online].